Cargando…
SIRT1 in the Development and Treatment of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related death worldwide. Current treatment options for inoperable HCCs have decreased therapeutic efficacy and are associated with systemic toxicity and chemoresistance. Sirtuin 1 (SIRT1) is a nicotinamide adenine dinucleotide...
Autores principales: | Farcas, Marius, Gavrea, Andrei-Alexandru, Gulei, Diana, Ionescu, Calin, Irimie, Alexandru, Catana, Cristina S., Berindan-Neagoe, Ioana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773871/ https://www.ncbi.nlm.nih.gov/pubmed/31608282 http://dx.doi.org/10.3389/fnut.2019.00148 |
Ejemplares similares
-
A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer
por: Braicu, Cornelia, et al.
Publicado: (2019) -
Hepatocellular Carcinoma: Tumorigenesis and Prediction Markers
por: Braicu, Cornelia, et al.
Publicado: (2009) -
Beyond Conventional: The New Horizon of Anti-Angiogenic microRNAs in Non-Small Cell Lung Cancer Therapy
por: Tirpe, Alexandru, et al.
Publicado: (2020) -
Ovarian endometriosis, a precursor of ovarian cancer: Histological aspects, gene expression and microRNA alterations (Review)
por: Gaia-Oltean, Adriana Ioana, et al.
Publicado: (2021) -
Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effects
por: Berindan-Neagoe, Ioana, et al.
Publicado: (2012)